Belgian Health Care REITs Stock News

UCB (ENXTBR:UCB) has kicked off FY 2025 with first half revenue of €3.5b and basic EPS of €2.50, following a FY 2024 second half that delivered €3.4b in revenue and basic EPS of €4.51. The company has reported an increase in revenue from €2.8b and basic EPS of €1.10 in the first half of 2024 to the latest €3.5b and €2.50, with trailing 12 month basic EPS of €8.20 on revenue of €7.7b. For investors, that mix of higher recent earnings, stronger trailing profitability and a 20.1% net margin...

Azelis Group (ENXTBR:AZE) shares are in focus after the company reported full year 2025 results showing lower sales and net income, alongside a proposed €0.226 per share dividend with a late June ex dividend date. See our latest analysis for Azelis Group. The full year 2025 results and lower proposed dividend come after a year where Azelis Group’s share price return slipped, with a year to date share price return of 10.12% and a 1 year total shareholder return decline of 53.49%, hinting that...

Interest in Syensqo (ENXTBR:SYENS) has picked up after the company reported 4% full year net sales growth in Composite Materials and exited its Oil & Gas unit, sharpening its focus as a pure play specialty company. See our latest analysis for Syensqo. That sharper focus has not yet shown up in the price, with the share price at €48.37 and recent momentum clearly weak, including a 7 day share price return of 37.94% decline and a 1 year total shareholder return of 30.03% decline. If Syensqo’s...

Recent performance snapshot argenx (ENXTBR:ARGX) has seen mixed share performance recently, with a small move over the past week, a modest gain over the past month, and a double digit decline across the past 3 months. Over a longer horizon, argenx shows a positive year to date return and a higher 1 year total return, while the 3 year and 5 year total returns are considerably above its shorter term moves. See our latest analysis for argenx. At a share price of €710.2, argenx’s recent 10.19% 3...

Earnings and dividend announcement set the tone Gimv (ENXTBR:GIMB) has drawn fresh attention after reporting net income of €173.31 million for the nine months to December 31, 2025, and confirming an annual dividend of €1.3650 per share. See our latest analysis for Gimv. The earnings release and dividend confirmation appear to have fed into a positive trend, with Gimv’s 1-day share price return of 1.95% and 7-day share price return of 4.32% lifting the share price to €47.1. The 1-year total...

Wondering if Solvay at €27.88 is offering good value right now, or if the best days are already priced in? This article breaks down what the current share price might be telling you. Over the short term the stock has returned 0.9% in the last 7 days and 7.1% over the past month. The year to date return sits at 2.0% and the 1 year return shows a 4.0% decline, compared with a 3 year return of 50.0% and 5 year return of 63.7%. Recent attention around Solvay has largely focused on how investors...

As European markets experience volatility amid global economic shifts, the pan-European STOXX Europe 600 Index recently hit a new high but ended the week with only a slight gain of 0.09%. This backdrop of fluctuating investor sentiment and economic expansion in key regions like the eurozone presents an intriguing environment for uncovering lesser-known stocks that might offer unique opportunities. In such conditions, identifying stocks with strong fundamentals and potential resilience to...

If you are wondering whether SCR-Sibelco is priced fairly today, you are not alone. The stock often attracts attention from investors trying to work out if they might be overpaying or missing an opportunity. Over the short term, the share price has been mixed, with a 1.3% return over the last 7 days, a 0.8% decline over 30 days, and returns of 12.7% decline year to date and 5.7% decline over the past year, extending to a 10.9% decline over five years. Recent news coverage has mainly focused...

Key Insights Significant control over Biotalys by private equity firms implies that the general public has more power...

As European markets experience volatility amid global concerns over AI disruption, the pan-European STOXX Europe 600 Index managed to hit a new high, ending the week with a slight gain. In such an environment, dividend stocks can offer investors a degree of stability and income potential, making them attractive options for those looking to navigate uncertain market conditions.

It's been a good week for Anheuser-Busch InBev SA/NV ( EBR:ABI ) shareholders, because the company has just released...

Shareholders might have noticed that KBC Group NV ( EBR:KBC ) filed its yearly result this time last week. The early...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Anheuser-Busch InBev (ENXTBR:ABI) has wrapped up FY 2025 with fourth quarter revenue of about US$15.6b and basic EPS of US$0.99, rounding out a year where trailing 12 month revenue reached roughly US$59.3b and EPS came in at US$3.45. Over the past few quarters, revenue has moved from US$14.8b in Q4 2024 to US$15.0b in Q2 2025 and US$15.1b in Q3 2025, while quarterly EPS has ranged between US$0.53 and US$1.08, setting up a picture of higher trailing profitability alongside a net profit margin...

Banqup Group SA ( EBR:BANQ ) shareholders would be excited to see that the share price has had a great month, posting a...

BNP Paribas Asset Management has disclosed crossing the 3% legal threshold of direct voting rights in Umicore. The disclosure reflects an increased stake that now exceeds the mandatory reporting level for shareholder voting power. Umicore (ENXTBR:UMI) is trading at €18.8, with the share price up 81.3% over the past year, while longer term returns over 3 and 5 years show declines of 37.6% and 55.1% respectively. This mix of strong recent performance and weaker multi year returns gives a...

Econocom Group (ENXTBR:ECONB) closed FY 2025 with second half revenue of €1.5b and net income from continuing operations of €34.5m, while trailing twelve month net income from continuing operations reached €53.2m. The company has seen half year revenue move from €1.4b in H2 2024 to €1.5b in H2 2025, with trailing twelve month revenue rising from €2.7b to €2.9b over the same comparison window. With net profit margins running at 1.8% over the last year and earnings growth expectations in focus,...

Key Insights Elia Group's significant private companies ownership suggests that the key decisions are influenced by...

It's been a good week for Lotus Bakeries NV ( EBR:LOTB ) shareholders, because the company has just released its latest...

If you have been wondering whether Anheuser-Busch InBev shares are offering good value at current levels, this article walks through what the numbers are actually saying about the stock. The share price recently closed at US$63.66, with reported returns of 4.2% over 7 days, 12.6% over 30 days, 17.0% year to date, 32.3% over 1 year, 20.1% over 3 years, and 23.4% over 5 years. These figures provide useful context before assessing what the business might be worth. Recent coverage around...

Lotus Bakeries (ENXTBR:LOTB) has wrapped up FY 2025 with second half revenue of €697.7 million, basic EPS of €114.31 and net income of €92.9 million, while trailing twelve month revenue sits at about €1.4 billion with EPS of €212.06. The company has seen revenue move from €632.7 million in the second half of 2024 to €657.3 million in the first half of 2025 and €697.7 million in the second half of 2025. EPS over the same periods stepped from €99.12 to €97.74 and then €114.31, setting up a...

Key Insights Significant control over Groupe Bruxelles Lambert by private companies implies that the general public has...

Key Insights Using the 2 Stage Free Cash Flow to Equity, Umicore fair value estimate is €29.83 Umicore's €19.68 share...

It's been a sad week for Melexis NV ( EBR:MELE ), who've watched their investment drop 16% to €53.25 in the week since...